montanensis立克次体 IgG ELISA试剂盒

R. montanensis? IgG ELISA Kit

广州健仑生物科技有限公司

主要用途：用于检测人血清中的montanensis立克次体IgG抗体

产品规格：96T/盒

主要产品包括：包柔氏螺旋体菌、布鲁氏菌、贝纳特氏立克次体、土伦杆菌、钩端螺旋体、新型立克次体、恙虫病、立克次体、果氏巴贝西虫、马焦虫、牛焦虫、利什曼虫、新包虫、弓形虫、猫流感病毒、猫冠状病毒、猫疱疹病毒、犬瘟病毒、犬细小病毒等病原微生物的 IFA、MIF、ELISA试剂。

montanensis立克次体 IgG ELISA试剂盒

我司还提供其它进口或国产试剂盒：登革热、疟疾、西尼罗河、立克次体、无形体、蜱虫、恙虫、利什曼原虫、RK39、汉坦病毒、深林脑炎、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

欢迎咨询

欢迎咨询2042552662

montanensis立克次体 IgG ELISA试剂盒

二维码扫一扫

【公司名称】 广州健仑生物科技有限公司
【】    杨永汉 
【】 
【腾讯 】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-3室
【企业文化】

2014年8月12日STEM CELL REPORTS期刊封面文章介绍人类诱导多能干细胞(iPSC)分化成心肌细胞(iPS-CM)为研究长-QT综合症。患者衍生的iPS-CM出现*的机遇对研究遗传心律失常综合症在天然组织中。旧金山格莱斯顿学院的研究人员从病人携带的两种不同形态的长-QT综合症的细胞中生成心肌细胞，然后用这些iPS-CM揭示普通的致心律失常性细胞通路。这些发现揭示功能上的定向治疗是不依赖于特定长-QT突变这种综合症患者可能受益。图片由Paweena Lizarraga 和 Luke Judge制作。红色表示心脏肌钙蛋白T，心脏肌原纤维的一个重要标志。黄色/绿色与其他thin-filament对应相关的蛋白质。蓝色(DAPI)表示细胞核。
英国《每日电讯报》8月12日发表题为《蜂毒、蛇毒、蝎毒有可能用来抗击癌症》的报道称，实验表明，蜜蜂、蛇和蝎子分泌的毒液能杀死肿瘤，因此毒素可能用来抗击癌症。
研究人员发现，昆虫蜇伤处或爬行动物咬伤处含有的毒液在实验室里能杀死抗原抗体癌和皮肤癌细胞。他们设法将这些毒素封入微粒内，以免毒素泄入血液并伤害患者。
伊利诺伊大学的迪帕尼扬·帕恩说：“我们在实验室里安全使用被封入纳米大小微粒中的毒素来对付抗原抗体癌和黑素瘤细胞。这种微粒在伪装后能躲过免疫系统，将毒素直接送入癌细胞，不伤害正常组织。我们将制造出的毒肽封装在纳米微粒中，不会溶于血液而带来副作用。”
报道说，蛇毒、蜂毒和蝎毒中含有蛋白质和肽，可附着在癌细胞壁上。但这些毒素也会损害心脏和神经细胞，造成皮下出血。帕恩说：“主要的问题是我们如何控制其毒性。”
研究小组在蜂毒中发现了一种叫做蜂毒肽的物质，它能阻止癌细胞增殖。
日本东海大学基础学院再生医学系肌肉生理学及细胞生物学组Dr. Tetsuro Tamaki所在团队，从骨骼肌中分离出干细胞，并将其命名为骨骼肌源性多能干细胞。骨骼肌源性多能干细胞在受损外周神经处能分化为雪旺氏束膜和/神经内膜细胞、血管周细胞、内皮细胞和平滑肌细胞。
Dr. Tetsuro Tamaki研究发现，与健康自体神经移植相比，神经导管复合骨骼肌源性多能干细胞桥接更有利于周围神经轴突再生，可修复长节段周围神经缺损。作者认为，此方法的应用将极大提高人损伤周围神经的治疗效果。此观点发表在《中国神经再生研究(英文版)》2014年7月第14期杂志上。

August 12, 2014 STEM CELL REPORTS Journal Cover Article Introduction Differentiation of human induced pluripotent stem cells (iPSCs) into cardiomyocytes (iPS-CMs) is the study of long-QT syndromes. Patient Derived iPS-CM presents an unprecedented opportunity to study genetic arrhythmia syndromes in native tissues. Researchers at Gladstone College in San Francisco generated cardiomyocytes from cells of two different forms of long-QT syndromes carried by patients and then used these iPS-CMs to reveal common pathways of the arrhythmic cells. These findings reveal that functional targeted therapy may benefit patients with a syndrome that does not depend on a particular long-QT mutation. Picture by Paweena Lizarraga and Luke Judge. Red indicates cardiac troponin T, an important marker of cardiac myofibrils. Yellow / green and other related proteins. Blue (DAPI) represents the nucleus.
The British Daily egraph website published a report on August 12 entitled "Bee venom, snake venoms, scorpion venom may be used to fight cancer," the report said that experiments show that bees, snakes and scorpions secreted venom can kill the tumor, So toxins can be used to fight cancer.
Researchers found that venom contained in insect stings or reptile bites can kill both antigen-antibody and skin cancer cells in the lab. They try to encapsulate these toxins in the particles so that no toxins can leak into the bloodstream and harm the patient.
"We are in the laboratory safe to use toxins encapsulated in nano-sized particles to fight antigen-presenting cancers and melanoma cells," said Dipani Jan Parne of the University of Illinois at University of Illinois at Urbana-Champaign. "These particles escape the immune system after being camouflaged , The toxin directly into the cancer cells, do not harm the normal tissue.We will create the toxic peptide encapsulated in the nanoparticles, will not dissolve in the blood and bring side effects.
Reported that snake venom, bee venom and scorpion venom contain proteins and peptides, can be attached to the cancer cell wall. But these toxins can also damage the heart and nerve cells, causing subcutaneous hemorrhage. Parne said: "The main issue is how we control its toxicity."
The team found a compound called bee venom in bee venom that prevents cancer cells from proliferating.
Department of Reproductive Medicine, Tokai University School of Reproductive Medicine Department of Muscle Physiology and Cell Biology Dr. Tetsuro Tamaki's team, which has stem cells isolated from skeletal muscle, names it skeletal myogenic pluripotent stem cells. Skeletal muscle-derived pluripotent stem cells differentiate into Schwann's fascia and / endoneurium cells, perivascular cells, endothelial cells and smooth muscle cells at damaged peripheral nerves.
Dr. Tetsuro Tamaki study found that compared with healthy autologous nerve graft, neural conduit composite skeletal myeloid pluripotent stem cell bridging is more conducive to axonal regeneration of the peripheral nerve, can repair long segment peripheral nerve defects. The authors believe that the application of this method will greatly improve the treatment of peripheral nerve injury. This view is published in the "Chinese Journal of Nerve Regeneration Research (English version)" 2014 July 14th magazine.